Losartan to Improve Hip Microfracture

Stopped early · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Hip Osteoarthritis, Hip Impingement Syndrome, Cartilage Damage, Fibrosis

In brief

Phase I/IIA randomized, double-blind, placebo-controlled clinical trial to assess safety and efficacy of oral losartan for improving cartilage repair following microfracture to treat focal cartilage defects during hip arthroscopy.

Key facts

Study ID
NCT04212650
Run by
Steadman Philippon Research Institute
People needed
1
Starts
2020-08-07
Expected to finish
2020-12-04
Last updated by the study team
2023-10-30

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.